IP Library Granted Patent US 10,954,491
Granted Patent B2
US 10,954,491 · App. 15/535,819 · Granted Mar 23, 2021

Pestivirus

Inventors: Ad de Groof (Groesbeek, NL); Lars Guelen (Nijmegen, NL); Carla Christina Schrier (Boxmeer, NL); Martin Deijs (Huizen, NL); Cornelia Maria van der Hoek (Amsterdam, NL)
Assignee: Intervet Inc.
C12N7/00C07K14/005C07K16/10C12Q1/701G01N33/56983A61K39/00C12N2770/24321C12N2770/24322C12N2770/24334G01N2333/183
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,491
App. No.
15/535,819
Granted
Mar 23, 2021
Kind
B2
Abstract

The present invention relates to a novel porcine pestivirus, to proteins of the virus and to vaccines based upon the virus and proteins thereof. The invention also relates to DNA fragments comprising a gene of the virus and to DNA vaccines based upon genes of the virus. Furthermore the invention relates to antibodies that are reactive with the novel virus and to diagnostic tests for the detection of the virus or antibodies against the virus.

Claims (5)

1. A gene encoding an E2 protein produced by heterologous expression in a non-pestivirus expression system, wherein the nucleotide sequence of said gene has a level of identity of at least 80% to the nucleotide sequence of SEQ ID NO: 3.

2. The gene of claim 1 , wherein the non-pestivirus expression system is a baculovirus or yeast expression system.

3. A DNA fragment comprising the E2 gene of claim 1 , wherein the E2 gene is under the control of a functional heterologous promoter.

4. A method of generating the E2 protein of claim 1 , comprising expressing a gene encoding the E2 protein in a non-pestivirus expression system, wherein the nucleotide sequence of said gene has a level of identity of at least 80% to the nucleotide sequence of SEQ ID NO: 3.

5. A method of generating the E2 protein of claim 1 , comprising incubating cells transfected with the non-pestivirus expression system, lysing the incubated cells, purification of the E2 protein from the lysed cells, and subsequent formulation of the purified E2 protein.

Assignments (4)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: DE GROOF, AD; GUELEN, LARS; SCHRIER, CARLA CHRISTINA
To: INTERVET INC.
Reel/Frame 042715/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: DEIJS, MARTIN; VAN DER HOEK, CORNELIA MARIA
To: ACADEMISCH MEDISCH CENTRUM
Reel/Frame 042716/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: ACADEMISCH MEDISCH CENTRUM
To: INTERVET INC.
Reel/Frame 042716/0437 →
Priority Claims (1)
EP 14199430 · Dec 19, 2014 · regional
Continuity (1)
Related Publication 20170342387A1 · Nov 30, 2017